A convergent strategy for the synthesis of beta-cyclodextrin analogues is reported, utilizing preferential cyclodimerization of an azido-alkyne trisaccharide via Cu(I)-catalyzed [3 + 2] dipolar cycloaddition of the alkyne and azide functional groups. The resultant oligosaccharide macrocycle retains the binding propensity of cyclodextrins, as demonstrated by the similar ANS association constants measured for macrocycle 1 and beta-cyclodextrin. This new synthetic strategy opens up new avenues for modular preparation of functionally diverse cyclodextrin analogues that are otherwise inaccessible.
Negative beats positive: A channel composed of oligoether chains attached by amine groups to β‐cyclodextrin mediates the transport of halides across a phospholipid bilayer (see scheme) at faster rates than those observed for monovalent cations. Protonation of the amine linkages likely explains the preferential anion transport.
A gated synthetic ion channel with beta-cyclodextrin as the pore and azobenzene as the gate is reported. Irradiation converts a tethered trans-azobenzene to cis-azobenzene which likely transforms the channel from a self-inclusion complex to a dissociated structure. This transformation results in an increase in anion transport and a decrease in cation transport across a phospholipid vesicle membrane.
[structure: see text] A highly convergent strategy for the synthesis of C3- or C2-symmetric oligosaccharide macrocycles is reported. Molecular modeling indicates these macrocycles possess sterically congested cavities. Weak host-guest interactions are observed that should be beneficial for applications such as functionalized molecular pores.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.